A diagnostic paradigm for resectable liver lesions: To biopsy or not to biopsy?

HPB

Volumn 11, Issue 7, 2009, Pages 533-540

  Cresswell, Adrian B ^a   Welsh, Fenella K S ^a   Rees, Myrddin ^a  

^a BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

Biopsy; Liver malignancy; Tumour seeding

Indexed keywords

ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN; GADOBENATE DIMEGLUMINE; GADOXETIC ACID; TUMOR MARKER;

ASPIRATION BIOPSY; BILE LEAKAGE; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; HEMOBILIA; HUMAN; INCIDENCE; INFECTION; LIVER BIOPSY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; MORBIDITY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS; PNEUMOTHORAX; POSTOPERATIVE PAIN; PREOPERATIVE EVALUATION; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; TUMOR SEEDING;

EID: 73349110950     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00081.x     Document Type: Review

References (70)

1. Gonzalez HD, Figueras J. (2007) Practical questions in liver metastases of colorectal cancer: general principles of treatment. HPB (Oxford) 9:251-258.
2. Chun YS, Vauthey JN. (2007) Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol 33 (Suppl. 2):52-58.
3. Jones OM, Rees M, John TG, Bygrave S, Plant G. (2005) Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection. Br J Surg 92:1165-1168.
4. Ryd W, Hagmar B, Eriksson O. (1983) Local tumour cell seeding by fine-needle aspiration biopsy. A semi-quantitative study. Acta Pathol Microbiol Immunol Scand [A] 91:17-21.
5. Grant A, Neuberger J. (1999) Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut 45 (Suppl. 4): IV1-IV11.
6. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. (1995) Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 36:437-441.
7. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. (1990) A 21-year experience with major haemorrhage after percutaneous liver biopsy. Gastroenterology 99:1396-1400.
8. Perrault J, McGill DB, Ott BJ, Taylor WF. (1978) Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 74:103-106.
9. Knauer CM. (1978) Percutaneous biopsy of the liver as a procedure for outpatients. Gastroenterology 74:101-102.
10. Minuk GY, Sutherland LR, Wiseman DA, MacDonald FR, Ding DL. (1987) Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular haematomas in patients randomized to 6 or 24 h of bed rest after percutaneous liver biopsy. Gastroenterology 92:290-293.
11. Caturelli E, Ghittoni G, Roselli P, De Palo M, Anti M. (2004) Fine-needle biopsy of focal liver lesions: the hepatologist's point of view. Liver Transpl 10 (2 Suppl. 1):26-29.
12. Giorgio A, Tarantino L, de Stefano G et al. (2003) Complications after interventional sonography of focal liver lesions: a 22-year single-centre experience. J Ultrasound Med 22:193-205.
13. Smith EH. (1991) Complications of percutaneous abdominal fine-needle biopsy. Review. Radiology 178:253-258.
14. Nyman RS, Cappelen-Smith J, Brismar J, von Sinner W, Kagevi I. (1995) Yield and complications in ultrasound-guided biopsy of abdominal lesions. Comparison of fine-needle aspiration biopsy and 1.2-mm needle core biopsy using an automated biopsy gun. Acta Radiol 36:485-490.
15. Stewart CJ, Coldewey J, Stewart IS. (2002) Comparison of fine-needle aspiration cytology and needle core biopsy in the diagnosis of radiologically detected abdominal lesions. J Clin Pathol 55:93-97.
16. Al-Leswas D, O'Reilly DA, Poston GJ. (2008) Biopsy of solid liver tumours: adverse consequences. Hepatobiliary Pancreat Dis Int 7:325-327.
17. Ferrucci JT, Wittenberg J, Margolies MN, Carey RW. (1979) Malignant seeding of the tract after thin-needle aspiration biopsy. Radiology 130:345-346.
18. Metcalfe MS, Bridgewater FH, Mullin EJ, Maddern GJ. (2004) Useless and dangerous - fine-needle aspiration of hepatic colorectal metastases. BMJ 328:507-508.
19. Scheele J, Altendorf-Hofmann A. (1990) Tumour implantation from needle biopsy of hepatic metastases. Hepatogastroenterology 37:335-337.
20. Ohlsson B, Nilsson J, Stenram U, Akerman M, Tranberg KG. (2002) Percutaneous fine-needle aspiration cytology in the diagnosis and management of liver tumours. Br J Surg 89:757-762.
21. Rodgers MS, Collinson R, Desai S, Stubbs RS, McCall JL. (2003) Risk of dissemination with biopsy of colorectal liver metastases. Dis Colon Rectum 46:454-458; discussion 458-459.
22. Durand F, Regimbeau JM, Belghiti J et al. (2001) Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 35:254-258.
23. Kim SH, Lim HK, Lee WJ, Cho JM, Jang HJ. (2000) Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 25:246-250.
24. Kosugi C, Furuse J, Ishii H et al. (2004) Needle tract implantation of hepatocellular carcinoma and pancreatic carcinoma after ultrasound-guided percutaneous puncture: clinical and pathologic characteristics and the treatment of needle tract implantation. World J Surg 28:29-32.
25. Liu YW, Chen CL, Chen YS, Wang CC, Wang SH, Lin CC. (2007) Needle tract implantation of hepatocellular carcinoma after fine-needle biopsy. Dig Dis Sci 52:228-231.
26. Qua CS, Wong CH, Goh KL. (2008) Tumour seeding following percutaneous needle biopsy of hepatocellular carcinoma. Singapore Med J 49:e8-e11.
27. Takamori R, Wong LL, Dang C, Wong L. (2000) Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary? Liver Transpl 6:67-72.
28. Chapoutot C, Perney P, Fabre D et al. (1999) [Needle-tract seeding after ultrasound-guided puncture of hepatocellular carcinoma. A study of 150 patients.] Gastroenterol Clin Biol 23:552-556.
29. Huang GT, Sheu JC, Yang PM, Lee HS, Wang TH, Chen DS. (1996) Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma - a study based on 420 patients. J Hepatol 25:334-338.
30. Silva MA, Hegab B, Hyde C, Guo B, Buckels JA, Mirza DF. (2008) Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 57:1592-1596.
31. Young AL, Malik HZ, Abu-Hilal M et al. (2007) Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Coll Surg 205:453-462.
32. Durand F, Belghiti J, Paradis V. (2007) Liver transplantation for hepato-cellular carcinoma: role of biopsy. Liver Transpl 13 (11 Suppl. 2):17-23.
33. Bruix J, Sherman M. (2005) Management of hepatocellular carcinoma. Hepatology 42:1208-1236.
34. Torzilli G, Minagawa M, Takayama T et al. (1999) Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 30:889-893.
35. Rizzi PM, Kane PA, Ryder SD et al. (1994) Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation. Gastroenterology 107:1425-1429.
36. Broelsch CE, Frilling A, Malago M. (2005) Should we expand the criteria for liver transplantation for hepatocellular carcinoma - yes, of course! J Hepatol 43:569-573.
37. Suh KS, Cho EH, Lee HW, Shin WY, Yi NJ, Lee KU. (2007) Liver transplantation for hepatocellular carcinoma in patients who do not meet the Milan criteria. Dig Dis 25:329-333.
38. Pawlik TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, Choti MA. (2007) Preoperative assessment of hepatocellular carcinoma tumour grade using needle biopsy: impl ications for transplant eligibility. Ann Surg 245:435-442.
39. Marsh JW, Dvorchik I. (2005) Should we biopsy each liver mass suspicious for hepatocellular carcinoma before liver transplantation? Yes. J Hepatol 43:558-562.
40. Compagnon P, Grandadam S, Lorho R et al. (2008) Liver transplantation for hepatocellular carcinoma without preoperative tumour biopsy. Transplantation 86:1068-1076.
41. Ward J. (2006) New MR techniques for the detection of liver metastases. Cancer Imaging 6:33-42.
42. Kumar Y, Pinedo IR, Tapuria N, Zabron A, Davidson BR. (2008) A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases. Eur J Gastroenterol Hepatol 20:1006-1011.
43. Colli A, Fraquelli M, Casazza G et al. (2006) Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 101:513-523.
44. Quaia E, D'Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M. (2006) Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 16:1599-1609.
45. Papagrigoriadis S. (2007) Follow-up of patients with colorectal cancer: the evidence is in favour but we are still in need of a protocol. Int J Surg 5:120-128.
46. Irvine T, Scott M, Clark CI. (2007) A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer. Colorectal Dis 9:527-531.
47. Lauro S, Trasatti L, Bordin F et al. (1999) Comparison of CEA, MCA, CA 15-3 and CA 27-29 in follow-up and monitoring therapeutic response in breast cancer patients. Anticancer Res 19:3511-3515.
48. Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B. (1995) Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 196:471-478.
49. Lencioni R, Della Pina C, Bruix J et al. (2005) Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography. Dig Dis Sci 50:533-537.
50. Muller RD, Vogel K, Neumann K et al. (1999) SPIO-MR imaging versus double-phase spiral CT in detecting malignant lesions of the liver. Acta Radiol 40:628-635.
51. Semelka RC, Cance WG, Marcos HB, Mauro MA. (1999) Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 213:86-91.
52. Seneterre E, Taourel P, Bouvier Y et al. (1996) Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200:785-792.
53. Kim MJ, Kim JH, Chung JJ, Park MS, Lim JS, Oh YT. (2003) Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. Radiology 228: 719-726.
54. Poeckler-Schoeniger C, Koepke J, Gueckel F, Sturm J, Georgi M. (1999) MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesions. Magn Reson Imaging 17:383-392.
55. Reimer P, Jahnke N, Fiebich M et al. (2000) Hepatic lesion detection and characterization: value of non-enhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217:152-158.
56. Ward J, Chen F, Guthrie JA et al. (2000) Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology 214:159-166.
57. Mitchell DG. (1992) Focal manifestations of diffuse liver disease at MR imaging. Radiology 185:1-11.
58. Ward J, Guthrie JA, Wilson D et al. (2003) Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging - comparison of optimized sequences. Radiology 228:709-718.
59. Low RN, Barone RM, Lacey C, Sigeti JS, Alzate GD, Sebrechts CP. (1997) Peritoneal tumour: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 204:513-520.
60. Ward J, Robinson PJ, Guthrie JA et al. (2005) Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium-and SPIO-enhanced MR imaging. Radiology 237:170-180.
61. Konopke R, Bunk A, Kersting S. (2008) Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy. Ultraschall Med 29 (Suppl. 4):203-209.
62. Bipat S, van Leeuwen MS, Comans EF et al. (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysis. Radiology 237:123-131.
63. 18F-FDG PET/CT in colorectal liver metastases - comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging 35:1323-1329.
64. Taketa K, Endo Y, Sekiya C et al. (1993) A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 53:5419-5423.
65. Tang Y, Yamashita Y, Arakawa A et al. (1999) Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 172:1547-1554.
66. Horigome H, Nomura T, Saso K, Itoh M, Joh T, Ohara H. (1999) Limitations of imaging diagnosis for small hepatocellular carcinoma: comparison with histological findings. J Gastroenterol Hepatol 14:559-565.
67. Saada J, Bhattacharya S, Dhillon AP et al. (1997) Detection of small hepatocellular carcinomas in cirrhotic livers using iodized oil computed tomography. Gut 41:404-407.
68. Torzilli G, Olivari N, Del Fabbro D et al. (2004) Indication and contraindication for hepatic resection for liver tumours without fine-needle biopsy: validation and extension of an Eastern approach in a Western community hospital. Liver Transpl 10 (2 Suppl. 1):30-33.
69. Bismuth H, Adam R, Levi F et al. (1996) Resection of non-resectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509-520; discussion 520-522.
70. Abdalla EK, Hicks ME, Vauthey JN. (2001) Portal vein embolization: rationale, technique and future prospects. Br J Surg 88:165-175.